{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:42:01Z","timestamp":1787096521385,"version":"build-2736575974"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.addbeh.2018.09.020","type":"journal-article","created":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T17:18:48Z","timestamp":1537118328000},"page":"35-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Epidemiology of hallucinogen use in the U.S. results from the National epidemiologic survey on alcohol and related conditions III"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3400-1744","authenticated-orcid":false,"given":"Nadav","family":"Shalit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5665-0385","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaul","family":"Lev-Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.addbeh.2018.09.020_bb0005","first-page":"9","article-title":"Psychedelic experience as a Heuristic Tool for Exploring the mind and the Brain","author":"Alyushin","year":"2011","journal-title":"NeuroQuantology"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0010","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"3","key":"10.1016\/j.addbeh.2018.09.020_bb0015","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00406-005-0624-4","article-title":"The enduring effects of abuse and related adverse experiences in childhood: A convergence of evidence from neurobiology and epidemiology","volume":"256","author":"Anda","year":"2006","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"8","key":"10.1016\/j.addbeh.2018.09.020_bb0020","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00204-015-1513-x","article-title":"The hallucinogenic world of tryptamines: An updated review","volume":"89","author":"Ara\u00fajo","year":"2015","journal-title":"Archives of Toxicology"},{"issue":"1","key":"10.1016\/j.addbeh.2018.09.020_bb0025","first-page":"9","article-title":"Phencyclidine intoxication and adverse effects: A clinical and pharmacological review of an illicit drug","volume":"8","author":"Bey","year":"2007","journal-title":"The California Journal of Emergency Medicine\/California Chapter of the American Academy of Emergency Medicine"},{"issue":"3","key":"10.1016\/j.addbeh.2018.09.020_bb0030","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0035","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pnpbp.2015.03.002","article-title":"Classic hallucinogens in the treatment of addictions","volume":"64","author":"Bogenschutz","year":"2016","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"4","key":"10.1016\/j.addbeh.2018.09.020_bb0040","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.euroneuro.2015.01.008","article-title":"Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans","volume":"25","author":"Bouso","year":"2015","journal-title":"European Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.addbeh.2018.09.020_bb0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0193-953X(05)70074-5","article-title":"Gender differences in substance use disorders","volume":"22","author":"Brady","year":"1999","journal-title":"The Psychiatric Clinics of North America"},{"issue":"4","key":"10.1016\/j.addbeh.2018.09.020_bb0050","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/0897190014566314","article-title":"Hallucinogen Persisting perception Disorder and risk of Suicide","volume":"29","author":"Brodrick","year":"2016","journal-title":"Journal of Pharmacy Practice"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0055","series-title":"Human universals","volume":"Vol. 220","author":"Brown","year":"1991"},{"issue":"9320","key":"10.1016\/j.addbeh.2018.09.020_bb0060","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0140-6736(02)08701-9","article-title":"Mescaline use for 5700 years","volume":"359","author":"Bruhn","year":"2002","journal-title":"The Lancet"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0065","series-title":"American Community Survey, 2012","author":"Bureau of the Census","year":"2013"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0070","first-page":"24","article-title":"The rise and Challenge of dark Net Drug Markets","author":"Buxton","year":"2015","journal-title":"Global Drugs Policy Observatory Policy Brief"},{"issue":"12","key":"10.1016\/j.addbeh.2018.09.020_bb0075","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/0269881116662634","article-title":"Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences","volume":"30","author":"Carbonaro","year":"2016","journal-title":"Journal of Psychopharmacology"},{"issue":"07","key":"10.1016\/j.addbeh.2018.09.020_bb0080","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1017\/S0033291715002901","article-title":"The paradoxical psychological effects of lysergic acid diethylamide (LSD)","volume":"46","author":"Carhart-Harris","year":"2016","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fnhum.2014.00020","article-title":"The entropic brain: A theory of conscious states informed by neuroimaging research with psychedelic drugs","volume":"8","author":"Carhart-Harris","year":"2014","journal-title":"Frontiers in Human Neuroscience"},{"issue":"1","key":"10.1016\/j.addbeh.2018.09.020_bb0090","doi-asserted-by":"crossref","first-page":"13187","DOI":"10.1038\/s41598-017-13282-7","article-title":"Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms","volume":"7","author":"Carhart-Harris","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0095","series-title":"2014 National Survey on Drug Use and Health: Detailed Tables","author":"Center for Behavioral Health Statistics and Quality","year":"2015"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0100","author":"Center for Health Statistics, N"},{"issue":"1","key":"10.1016\/j.addbeh.2018.09.020_bb0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/pmh.1245","article-title":"Reflective function as a mediator between childhood adversity, personality disorder and symptom distress","volume":"8","author":"Chiesa","year":"2014","journal-title":"Personality and Mental Health"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0110","series-title":"Social support: Theory, Research and applications","first-page":"73","article-title":"Measuring the Functional Components of Social support","author":"Cohen","year":"1985"},{"issue":"5","key":"10.1016\/j.addbeh.2018.09.020_bb0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/jat\/3.5.199","article-title":"Phencyclidine-related deaths: A report of nine fatal cases","volume":"3","author":"Cravey","year":"1979","journal-title":"Journal of Analytical Toxicology"},{"issue":"10","key":"10.1016\/j.addbeh.2018.09.020_bb0120","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1176\/appi.ajp.158.10.1687","article-title":"Electrophysiological evidence of serotonergic impairment in long-term MDMA (\u201cEcstasy\u201d) users","volume":"158","author":"Croft","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pnpbp.2015.03.011","article-title":"MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults","volume":"64","author":"Danforth","year":"2016","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"5","key":"10.1016\/j.addbeh.2018.09.020_bb0130","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4278\/ajhp.121023-QUAN-511","article-title":"Social support may protect against development of posttraumatic stress disorder: Findings from the heart and soul study","volume":"28","author":"Dinenberg","year":"2014","journal-title":"American Journal of Health Promotion"},{"issue":"10","key":"10.1016\/j.addbeh.2018.09.020_bb0135","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0033-3182(81)73092-5","article-title":"Drug-induced psychosis: Emergency diagnosis and management","volume":"22","author":"Disclafani","year":"1981","journal-title":"Psychosomatics"},{"issue":"3","key":"10.1016\/j.addbeh.2018.09.020_bb0140","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1542\/peds.111.3.564","article-title":"Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: The adverse childhood experiences study","volume":"111","author":"Dube","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.forsciint.2014.12.018","article-title":"The combined effects of alcohol and cannabis on driving: Impact on crash risk","volume":"248","author":"Dubois","year":"2015","journal-title":"Forensic Science International"},{"issue":"1","key":"10.1016\/j.addbeh.2018.09.020_bb0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-010-1916-6","article-title":"The role of early life stress as a predictor for alcohol and drug dependence","volume":"214","author":"Enoch","year":"2011","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.addbeh.2018.09.020_bb0155","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0749-3797(98)00017-8","article-title":"Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: The adverse childhood experiences (ACE) study","volume":"14","author":"Felitti","year":"1998","journal-title":"American Journal of Preventive Medicine"},{"issue":"3","key":"10.1016\/j.addbeh.2018.09.020_bb0160","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/oxfordjournals.schbul.a033339","article-title":"Patterns of current and lifetime substance use in schizophrenia","volume":"24","author":"Fowler","year":"1998","journal-title":"Schizophrenia Bulletin"},{"issue":"11","key":"10.1016\/j.addbeh.2018.09.020_bb0165","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0895-4356(98)00106-1","article-title":"Tests of data quality, scaling assumptions, and reliability of the SF- 36 in eleven countries: Results from the IQOLA Project","volume":"51","author":"Gandek","year":"1998","journal-title":"Journal of Clinical Epidemiology"},{"issue":"May","key":"10.1016\/j.addbeh.2018.09.020_bb0170","doi-asserted-by":"crossref","first-page":"378","DOI":"10.15288\/jsad.2015.76.378","article-title":"Nosologic Comparisons of DSM-IV and DSM-5 Alcohol and Drug Use Disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions \u2013 III","volume":"76","author":"Goldstein","year":"2015","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0175","author":"Gouzoulis-Mayfrank"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0180","series-title":"NESARC- III source and accuracy statement","author":"Grant","year":"2013"},{"issue":"8","key":"10.1016\/j.addbeh.2018.09.020_bb0185","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 Alcohol Use Disorder","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0190","first-page":"1","article-title":"Epidemiology of DSM-5 Drug Use Disorder","volume":"20852","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.addbeh.2018.09.020_bb0195","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.psc.2010.01.004","article-title":"Substance Abuse in Women","volume":"33","author":"Greenfield","year":"2010","journal-title":"Psychiatric Clinics of North America"},{"issue":"6","key":"10.1016\/j.addbeh.2018.09.020_bb0200","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/0269881108094300","article-title":"Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later","volume":"22","author":"Griffiths","year":"2008","journal-title":"Journal of Psychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.addbeh.2018.09.020_bb0205","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.drugalcdep.2012.11.010","article-title":"A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students","volume":"130","author":"Hallock","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.addbeh.2018.09.020_bb0210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/16066359609010756","article-title":"The use of hallucinogens in the treatment of addiction","volume":"4","author":"Halpern","year":"1996","journal-title":"Addiction Research"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0215","series-title":"Current topics in behavioral neurosciences","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/7854_2016_457","article-title":"A review of Hallucinogen Persisting Perception Disorder (HPPD) and an exploratory study of subjects claiming symptoms of HPPD","author":"Halpern","year":"2016"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0220","series-title":"Life Sciences. NIH Public Access","article-title":"Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine","author":"Halpin","year":"2014"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0225","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drugalcdep.2014.12.011","article-title":"The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): Procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample","volume":"148","author":"Hasin","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0230","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.drugalcdep.2015.03.027","article-title":"Procedural validity of the AUDADIS-5 depression, anxiety and post-traumatic stress disorder modules: Substance abusers and others in the general population","volume":"152","author":"Hasin","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0235","series-title":"Psychiatric research interview for substance use and mental disorders, diagnostic and statistical manual of mental disorders, fifth edition (PRISM-5) version","author":"Hasin","year":"2011"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0240","series-title":"Biological Psychiatry","first-page":"1509","article-title":"The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders","volume":"Vol. 46","author":"Heim","year":"1999"},{"issue":"9","key":"10.1016\/j.addbeh.2018.09.020_bb0245","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1177\/0269881115598338","article-title":"Psilocybin, psychological distress, and suicidality","volume":"29","author":"Hendricks","year":"2015","journal-title":"Journal of Psychopharmacology"},{"issue":"3","key":"10.1016\/j.addbeh.2018.09.020_bb0250","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/0269881114565653","article-title":"Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population","volume":"29","author":"Hendricks","year":"2015","journal-title":"Journal of Psychopharmacology"},{"issue":"5","key":"10.1016\/j.addbeh.2018.09.020_bb0255","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/2045125312451270","article-title":"Hallucinogen-persisting perception disorder","volume":"2","author":"Hermle","year":"2012","journal-title":"Therapeutic Advances in Psychopharmacology"},{"issue":"4_suppl","key":"10.1016\/j.addbeh.2018.09.020_bb0260","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1359786810385490","article-title":"Review: Suicide and schizophrenia: A systematic review of rates and risk factors","volume":"24","author":"Hor","year":"2010","journal-title":"Journal of Psychopharmacology"},{"issue":"4","key":"10.1016\/j.addbeh.2018.09.020_bb0265","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1176\/ajp.126.4.565","article-title":"Flashbacks: Recurrent intrusive images after the use of LSD","volume":"126","author":"Horowitz","year":"1969","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.addbeh.2018.09.020_bb0270","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1146\/annurev.clinpsy.4.022007.141157","article-title":"Behavioral Disinhibition and the Development of Early-Onset Addiction: Common and specific Influences","volume":"4","author":"Iacono","year":"2008","journal-title":"Annual Review of Clinical Psychology"},{"issue":"3","key":"10.1016\/j.addbeh.2018.09.020_bb0275","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/0269881114568039","article-title":"Psychedelics not linked to mental health problems or suicidal behavior: A population study","volume":"29","author":"Johansen","year":"2015","journal-title":"Journal of Psychopharmacology"},{"issue":"4","key":"10.1016\/j.addbeh.2018.09.020_bb0280","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00005053-196704000-00010","article-title":"Prolonged adverse Reactions from Unsupervised use of Hallucinogenic Drugs","volume":"144","author":"Kleber","year":"1967","journal-title":"The Journal of Nervous and Mental Disease"},{"issue":"5","key":"10.1016\/j.addbeh.2018.09.020_bb0285","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1037\/a0020327","article-title":"Linking \u201cbig\u201d personality traits to anxiety, depressive, and substance use disorders: A meta-analysis","volume":"136","author":"Kotov","year":"2010","journal-title":"Psychological Bulletin"},{"issue":"8","key":"10.1016\/j.addbeh.2018.09.020_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063972","article-title":"Psychedelics and Mental Health: A Population Study","volume":"8","author":"Krebs","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.addbeh.2018.09.020_bb0295","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1002\/hbm.23234","article-title":"LSD-induced entropic brain activity predicts subsequent personality change","volume":"37","author":"Lebedev","year":"2016","journal-title":"Human Brain Mapping"},{"issue":"30","key":"10.1016\/j.addbeh.2018.09.020_bb0300","doi-asserted-by":"crossref","first-page":"10937","DOI":"10.1523\/JNEUROSCI.5302-10.2011","article-title":"Longitudinal Development of Human Brain Wiring Continues from Childhood into Adulthood","volume":"31","author":"Lebel","year":"2011","journal-title":"Journal of Neuroscience"},{"issue":"1","key":"10.1016\/j.addbeh.2018.09.020_bb0305","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1521-0391.2013.00321.x","article-title":"Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: Results from a large representative sample","volume":"22","author":"Lev-Ran","year":"2013","journal-title":"American Journal on Addictions"},{"issue":"8","key":"10.1016\/j.addbeh.2018.09.020_bb0310","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.euroneuro.2014.05.008","article-title":"Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases","volume":"24","author":"Litjens","year":"2014","journal-title":"European Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.addbeh.2018.09.020_bb0315","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1177\/0269881111420188","article-title":"Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness","volume":"25","author":"MacLean","year":"2011","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"6","key":"10.1016\/j.addbeh.2018.09.020_bb0320","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1037\/h0034411","article-title":"Long-term psychological effects of LSD","volume":"79","author":"McWilliams","year":"1973","journal-title":"Psychological Bulletin"},{"issue":"1","key":"10.1016\/j.addbeh.2018.09.020_bb0325","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ntt.2006.10.010","article-title":"Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry","volume":"29","author":"Medina","year":"2007","journal-title":"Neurotoxicology and Teratology"},{"issue":"2","key":"10.1016\/j.addbeh.2018.09.020_bb0330","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1037\/a0035248","article-title":"Validation of Interpersonal support Evaluation List-12 (ISEL-12) scores among English- and Spanish-speaking Hispanics\/Latinos from the HCHS\/SOL Sociocultural Ancillary Study","volume":"26","author":"Merz","year":"2014","journal-title":"Psychological Assessment"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0335","series-title":"Novel psychopharmacological therapies for psychiatric disorders: Psilocybin and MDMA. The Lancet Psychiatry","author":"Mithoefer","year":"2016"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0340","series-title":"Neuroimaging in moderate MDMA use: A systematic review. Neuroscience and Biobehavioral Reviews","author":"Mueller","year":"2016"},{"issue":"1","key":"10.1016\/j.addbeh.2018.09.020_bb0345","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/schbul\/16.1.31","article-title":"Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates. Special issue: Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates","volume":"16","author":"Mueser","year":"1990","journal-title":"Schizophrenia Bulletin"},{"issue":"9","key":"10.1016\/j.addbeh.2018.09.020_bb0350","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/0269881115596156","article-title":"The link between use of psychedelic drugs and mental health problems","volume":"29","author":"Nesv\u00e5g","year":"2015","journal-title":"Journal of Psychopharmacology"},{"issue":"2","key":"10.1016\/j.addbeh.2018.09.020_bb0355","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","volume":"101","author":"Nichols","year":"2004","journal-title":"Hallucinogens. Pharmacology and Therapeutics"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0360","series-title":"Goodman and Gilman's the pharmacological basis of therapeutics","first-page":"574","article-title":"Drug addiction and drug abuse","author":"O'Brien","year":"2001"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0365","series-title":"Perceived risk of regular cannabis use in the United States from 2002 to 2012: Differences by sex, age, and race\/ethnicity. Drug and Alcohol Dependency","first-page":"232","volume":"Vol. 149","author":"Pacek","year":"2015"},{"issue":"3\u20134","key":"10.1016\/j.addbeh.2018.09.020_bb0370","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/00952999009001588","article-title":"Phencyclidine and Violent Deaths in St. Louis, Missouri: A survey of Medical Examiners' cases from 1977 through 1986","volume":"16","author":"Poklis","year":"1990","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"12","key":"10.1016\/j.addbeh.2018.09.020_bb0375","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"Journal of Psychopharmacology"},{"issue":"12","key":"10.1016\/j.addbeh.2018.09.020_bb0380","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1177\/0269881116652578","article-title":"The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging","volume":"30","author":"dos Santos","year":"2016","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0385","series-title":"Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003\u201311. Drug and Alcohol Dependence","first-page":"145","volume":"Vol. 140","author":"Schuermeyer","year":"2014"},{"issue":"JUNE","key":"10.1016\/j.addbeh.2018.09.020_bb0390","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1192\/bjp.186.6.457","article-title":"Can psychedelics have a role in psychiatry once again?","volume":"186","author":"Sessa","year":"2005","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0395","series-title":"MDMA and PTSD treatment: \u201cPTSD: From novel pathophysiology to innovative therapeutics.\u201d Neuroscience Letters","author":"Sessa","year":"2017"},{"issue":"1","key":"10.1016\/j.addbeh.2018.09.020_bb0400","first-page":"13","article-title":"Analysis of the lsd flashback","volume":"3","author":"Shick","year":"1970","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0405","series-title":"Intoxication: The Universal Drive For Mind-Altering Substances","author":"Siegel","year":"2005"},{"issue":"10","key":"10.1016\/j.addbeh.2018.09.020_bb0410","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/13154","article-title":"In vivo evidence for post-adolescent brain maturation in frontal and striatal regions [1]","volume":"2","author":"Sowell","year":"1999","journal-title":"Nature Neuroscience"},{"issue":"2","key":"10.1016\/j.addbeh.2018.09.020_bb0415","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.drugalcdep.2006.08.008","article-title":"Who is Becoming Hallucinogen Dependent soon after Hallucinogen Use Starts?","volume":"87","author":"Stone","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0420","series-title":"Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-48, HHS Publication No. (SMA) 14\u20134863","first-page":"11","volume":"1\u2013143","author":"Substance Abuse and Mental Health Services Administration","year":"2014"},{"issue":"11","key":"10.1016\/j.addbeh.2018.09.020_bb0425","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1176\/ajp.124.11.1483","article-title":"The \u201cbad trip\u201d--the etiology of the adverse LSD reaction","volume":"124","author":"Ungerleider","year":"1968","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.addbeh.2018.09.020_bb0430","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12888-016-1002-7","article-title":"Psychosis associated with acute recreational drug toxicity: A European case series","volume":"16","author":"Vallersnes","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0435","article-title":"Common liability to addiction and \u201cgateway hypothesis\u201d: Theoretical, empirical and evolutionary perspective","author":"Vanyukov","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2007.11.003","article-title":"Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies","author":"Verdejo-Garc\u00eda","year":"2008","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"9","key":"10.1016\/j.addbeh.2018.09.020_bb0445","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrn2884","article-title":"The neurobiology of psychedelic drugs: Implications for the treatment of mood disorders","volume":"11","author":"Vollenweider","year":"2010","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.addbeh.2018.09.020_bb0450","series-title":"Drug-activation of brain reward pathways. Drug and Alcohol Dependence","author":"Wise","year":"1998"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460318305355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460318305355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:35:01Z","timestamp":1759689301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460318305355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":90,"alternative-id":["S0306460318305355"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2018.09.020","relation":{},"ISSN":["0306-4603"],"issn-type":[{"value":"0306-4603","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of hallucinogen use in the U.S. results from the National epidemiologic survey on alcohol and related conditions III","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2018.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}